Technical Analysis for ASNS - Arsanis, Inc.

Grade Last Price % Change Price Change
grade D 13.63 -2.08% -0.29
ASNS closed down 2.08 percent on Friday, January 19, 2018, on 51 percent of normal volume.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Down
See historical ASNS trend table...

Date Alert Name Type % Chg
Jan 19 Outside Day Range Expansion 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 18 Narrow Range Bar Range Contraction -2.08%
Jan 18 NR7 Range Contraction -2.08%
Jan 18 Inside Day Range Contraction -2.08%
Jan 18 Wide Bands Range Expansion -2.08%
Jan 17 Wide Bands Range Expansion -0.58%
Jan 17 Upper Bollinger Band Touch Strength -0.58%
Jan 17 Down 3 Days in a Row Weakness -0.58%
Jan 16 Upper Bollinger Band Walk Strength -1.73%

Older signals for ASNS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Arsanis, Inc. is a United States-based company engaged in the discovery and development of monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections. The Company's mAbs focus on specific pathogens and pathogenic processes. Its product pipeline includes ASN100, ASN200, ASN300, ASN400 and ASN500. Its lead program, ASN100, is being studied to prevent hospital-acquired Staphylococcus aureus pneumonia in mechanically ventilated patients heavily colonized with Staphylococcus aureus in their respiratory tracts. Its ASN200 addresses the unmet medical need caused by drug-resistant extra-intestinal escherichia coli infections. Its ASN300 addresses the unmet medical need due to carbapenem-resistant klebsiella pneumoniae infections. Its ASN400 addresses the unmet medical need due to streptococcus pneumoniae, a leading cause of mortality among the elderly. The ASN500 program consisting of potent mAbs targeting respiratory syncytial virus (RSV), is in the discovery phase.
Is ASNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 19.73
52 Week Low 10.4
Average Volume 52,283
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 13.3968
10-Day Moving Average 14.0925
Average True Range 1.1876
ADX 13.15
+DI 18.47
-DI 14.44
Chandelier Exit (Long, 3 ATRs ) 11.5372
Chandelier Exit (Short, 3 ATRs ) 14.9328
Upper Bollinger Band 14.9757
Lower Bollinger Band 11.8179
Percent B (%b) 0.57
BandWidth 23.571301
MACD Line -0.0686
MACD Signal Line -0.2368
MACD Histogram 0.1682
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.61
Resistance 3 (R3) 14.69 14.44 14.44
Resistance 2 (R2) 14.44 14.20 14.40 14.39
Resistance 1 (R1) 14.04 14.04 13.92 13.96 14.33
Pivot Point 13.79 13.79 13.73 13.75 13.79
Support 1 (S1) 13.39 13.55 13.27 13.31 12.93
Support 2 (S2) 13.14 13.39 13.10 12.87
Support 3 (S3) 12.74 13.14 12.82
Support 4 (S4) 12.66